PDK1/Akt/PDE4D axis identified as a target for asthma remedy synergistic with β2ARagonists by a natural agent arctigenin
Allergy2015Vol. 70(12), pp. 1622–1632
Citations Over TimeTop 11% of 2015 papers
Rui Fang, Qi Cui, Jun Sun, Xiaojiang Duan, Xuan Ma, Wenbin Wang, Bin‐Feng Cheng, Yang Liu, Yanglong Hou, Gang Bai
Abstract
The PDK1/Akt/PDE4D axis serves as a novel asthma target, which may benefit airflow obstruction.
Related Papers
- → FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K–AKT Pathway(2014)162 cited
- → Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects(2013)21 cited
- → Forskolin Binding Sites and G-Protein Immunoreactivity in Rat Hearts During Aging(1994)39 cited
- → Virtual Docking Screening and QSAR Studies to Explore PI3K and mTOR Inhibitors Acting on AKT in Cancers(2020)1 cited
- → Solanine Interferes with AKT/p-AKT and PI3K/p-PI3K Pathway to Inhibit HIF and Destroy Cell Energy Metabolism(2021)1 cited